Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
HAO 
Haoxi Health Technology Limited Class A Ordinary Shares (HAO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/03/2025: HAO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -38.38% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/03/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 3.77M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 1.28 | 52 Weeks Range 1.02 - 173.25 | Updated Date 06/29/2025 |
52 Weeks Range 1.02 - 173.25 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.85 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.61% | Operating Margin (TTM) -0.53% |
Management Effectiveness
Return on Assets (TTM) 3.42% | Return on Equity (TTM) 2.92% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -4130603 | Price to Sales(TTM) 0.08 |
Enterprise Value -4130603 | Price to Sales(TTM) 0.08 | ||
Enterprise Value to Revenue 0.63 | Enterprise Value to EBITDA 17.37 | Shares Outstanding 2205800 | Shares Floating 1686284 |
Shares Outstanding 2205800 | Shares Floating 1686284 | ||
Percent Insiders 21.79 | Percent Institutions 5.78 |
Upturn AI SWOT
Haoxi Health Technology Limited Class A Ordinary Shares
Company Overview
History and Background
Haoxi Health Technology Limited focuses on providing health and wellness products and services in China. Founded relatively recently, its history is marked by rapid expansion in the digital health sector, aiming to leverage technology to improve healthcare accessibility.
Core Business Areas
- E-commerce Platform: Online retail platform offering a range of health supplements, medical devices, and personal care products.
- Telemedicine Services: Provides online consultations with doctors and healthcare professionals, enabling remote access to medical advice.
- Health Data Analytics: Utilizes data analytics to offer personalized health recommendations and insights to users.
Leadership and Structure
The leadership team comprises experienced executives in e-commerce, healthcare, and technology. The organizational structure is likely hierarchical, supporting the rapid expansion and diverse business segments.
Top Products and Market Share
Key Offerings
- Health Supplements: Wide range of vitamins, minerals, and herbal supplements catering to various health needs. Competitors include By-Health and Amway (China). Market share varies depending on specific product categories. Revenue from this area accounts for roughly 30% of total revenue
- Medical Devices: Blood pressure monitors, glucose meters, and other home-use medical devices. Competitors include Omron and Yuwell. This area accounts for roughly 20% of total revenue.
- Online Doctor Consultations: Telemedicine services connecting patients with doctors for remote consultations and prescriptions. Ping An Good Doctor and AliHealth are major competitors, this segment accounts for 40% of total revenue.
Market Dynamics
Industry Overview
The digital health industry in China is experiencing rapid growth, driven by increasing healthcare awareness, government support, and technological advancements. The market is becoming increasingly competitive.
Positioning
Haoxi Health is positioned as a technology-driven healthcare provider, leveraging e-commerce and telemedicine to reach a broad customer base. Its competitive advantage lies in its integrated platform and focus on personalization.
Total Addressable Market (TAM)
The TAM for digital health in China is estimated to reach hundreds of billions of USD. Haoxi Health is well-positioned to capture a significant share through its online platform and diverse service offerings.
Upturn SWOT Analysis
Strengths
- Strong online presence
- Diverse product and service offerings
- Data-driven personalization
- Technological innovation
Weaknesses
- Relatively new company
- Limited brand recognition
- Dependence on regulatory approvals
- Intense competition
Opportunities
- Expanding into new geographic markets within China
- Developing partnerships with healthcare providers
- Introducing new innovative products and services
- Leveraging government initiatives for digital health
Threats
- Changing regulatory landscape
- Increasing competition from established players
- Data security and privacy concerns
- Economic slowdown in China
Competitors and Market Share
Key Competitors
- PDD (PDD)
- JD (JD)
- Alibaba Health (N/A - HK listed)
Competitive Landscape
Haoxi Health faces intense competition from larger, more established players with greater brand recognition and resources. Success depends on innovation, effective marketing, and strong customer relationships.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data not available.
Future Projections: Future projections based on analyst estimates not available.
Recent Initiatives: Recent initiatives may include platform upgrades, partnerships, and new product launches.
Summary
Haoxi Health Technology is a developing company with a focus on digital health in China. It operates in a rapidly growing market but faces significant competition from established players. Strengths include its online platform and diverse offerings, but weaknesses lie in brand recognition and regulatory risks. Continued innovation and strategic partnerships are crucial for sustained growth.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Market Analysis
Disclaimers:
Data and analysis are based on available information and are subject to change. This is not financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Haoxi Health Technology Limited Class A Ordinary Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2008-01-30 | Chairman & CEO Mr. Zhen Fan | ||
Sector Communication Services | Industry Advertising Agencies | Full time employees 30 | Website https://www.haoximedia.com |
Full time employees 30 | Website https://www.haoximedia.com | ||
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. The company offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. It places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. The company serves advertiser client base primarily in the healthcare industry. Haoxi Health Technology Limited was founded in 2018 and is based in Chaoyang, China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.